SCHEMBL2716698

SCHEMBL2716698

CN(C)c1c(-c2ccccn2)c(CCN)nc2ccc(F)cc12

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 10/20 0.49
PIK3CB P42338 9/20 0.49
PIK3CG P48736 9/20 0.49
PIK3CA P42336 8/20 0.49
METAP2 P50579 1/20 0.39
METAP1 P53582 1/20 0.39
CBFB Q13951 1/20 0.39
FFAR1 O14842 2/20 0.37
LMNA P02545 2/20 0.36
IDO1 P14902 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MITF O75030 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HIF1A Q16665 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6121716 0.86 CBFB (0.44) PIK3CDPIK3CBPIK3CGPIK3CAMETAP2
SCHEMBL2718718 0.84 PIK3CD (0.47) PIK3CDPIK3CBPIK3CGPIK3CAMETAP2
SCHEMBL2716683 0.83 PIK3CD (0.46) PIK3CDPIK3CBPIK3CGPIK3CALMNA
SCHEMBL2716696 0.79 PIK3CD (0.61) PIK3CDPIK3CBPIK3CGPIK3CAMETAP2
SCHEMBL2716751 0.78 PIK3CD (0.42) PIK3CDPIK3CBPIK3CGPIK3CAKDM4E
SCHEMBL2720602 0.78 PIK3CD (0.53) PIK3CDPIK3CBPIK3CGPIK3CA
SCHEMBL2720117 0.78 PIK3CD (0.69) PIK3CDPIK3CBPIK3CGPIK3CA
SCHEMBL2720107 0.77 PIK3CD (0.57) PIK3CDPIK3CBPIK3CGPIK3CA
SCHEMBL2716680 0.75 PIK3CD (0.47) PIK3CDPIK3CBPIK3CGPIK3CAMETAP2
SCHEMBL15320551 0.75 KDM4E (0.47) PIK3CDMETAP2METAP1CBFBFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445900-A2 POLYCYCLIC DERIVATIVES OF PYRIDINE AND THEIR USE IN THE TREATMENT OF (INTER ALIA) RHEUMATOID ARTHRITIS AND SIMILAR DISEASES Amgen, Inc (US) 2012-05-02 EP disclosed
WO-2010151740-A2 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2010-12-29 WO disclosed